Samar Kulkarni

970 total citations
27 papers, 704 citations indexed

About

Samar Kulkarni is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Samar Kulkarni has authored 27 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 11 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Samar Kulkarni's work include Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (8 papers) and Multiple Myeloma Research and Treatments (8 papers). Samar Kulkarni is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (8 papers) and Multiple Myeloma Research and Treatments (8 papers). Samar Kulkarni collaborates with scholars based in United Kingdom, United States and Australia. Samar Kulkarni's co-authors include R Powles, Seema Singhal, C Horton, Jayesh Mehta, Bhawna Sirohi, Jennifer Treleaven, J Treleaven, Diana Tait, Barbara C. Millar and Jayesh Mehta and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Samar Kulkarni

24 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samar Kulkarni United Kingdom 11 571 207 202 109 99 27 704
Carmen Martín Spain 19 646 1.1× 252 1.2× 246 1.2× 173 1.6× 153 1.5× 47 916
Ming Jiang China 10 672 1.2× 237 1.1× 279 1.4× 166 1.5× 105 1.1× 37 885
Sabine Fürst France 16 589 1.0× 177 0.9× 191 0.9× 141 1.3× 56 0.6× 46 727
DW Beelen Germany 14 750 1.3× 262 1.3× 178 0.9× 171 1.6× 89 0.9× 18 877
A Iriondo Spain 19 625 1.1× 185 0.9× 255 1.3× 190 1.7× 116 1.2× 45 1.0k
R Clift United States 7 760 1.3× 239 1.2× 260 1.3× 63 0.6× 73 0.7× 8 834
W-S Min South Korea 15 572 1.0× 145 0.7× 143 0.7× 255 2.3× 111 1.1× 29 737
Pascual Balsalobre Spain 17 462 0.8× 141 0.7× 252 1.2× 118 1.1× 82 0.8× 57 782
Joachim Deeg United States 10 870 1.5× 335 1.6× 224 1.1× 141 1.3× 82 0.8× 17 1.0k
James Gajewski United States 11 635 1.1× 338 1.6× 246 1.2× 154 1.4× 59 0.6× 13 852

Countries citing papers authored by Samar Kulkarni

Since Specialization
Citations

This map shows the geographic impact of Samar Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samar Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samar Kulkarni more than expected).

Fields of papers citing papers by Samar Kulkarni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samar Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samar Kulkarni. The network helps show where Samar Kulkarni may publish in the future.

Co-authorship network of co-authors of Samar Kulkarni

This figure shows the co-authorship network connecting the top 25 collaborators of Samar Kulkarni. A scholar is included among the top collaborators of Samar Kulkarni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samar Kulkarni. Samar Kulkarni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kulkarni, Samar, John Murray, Mike Dennis, et al.. (2021). Use of Cryopreserved Allogeneic PBSC Results in Delayed Engraftment and Increased Incidence of Poor Graft Function. Blood. 138(Supplement 1). 1778–1778.
2.
Thirkettle, Sally, et al.. (2019). Implications for the monitoring of patients with multiple myeloma undergoing treatment with the anti-CD38 monoclonal daratumumab. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 57(2). 178–181. 1 indexed citations
3.
Salih, Zena, Jim Cavet, Mike Dennis, et al.. (2013). Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies. SHILAP Revista de lepidopterología. 2(4). 220–224. 5 indexed citations
4.
5.
Kulkarni, Samar, Unell Riley, Gareth J. Morgan, et al.. (2007). High Dose Methylprednisolone and Rituximab Is an Effective Therapy in Advanced Refractory Chronic Lymphocytic Leukaemia Resistant to Fludarabine Therapy.. Blood. 110(11). 3125–3125. 1 indexed citations
6.
7.
Sirohi, Bhawna, R Powles, Claudius Rudin, et al.. (2005). Re-use of the original infusional induction chemotherapy as salvage therapy in myeloma patients relapsing after one autograft. Hematology. 10(5). 361–364. 3 indexed citations
8.
Sirohi, Bhawna, Samar Kulkarni, & R Powles. (2001). Some early phase II trials in previously untreated multiple myeloma: The royal marsden experience. Seminars in Hematology. 38(3). 209–218. 8 indexed citations
9.
Powles, R, Jayesh Mehta, Samar Kulkarni, et al.. (2000). Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. The Lancet. 355(9211). 1231–1237. 268 indexed citations
10.
Kulkarni, Samar, R Powles, Jennie Treleaven, et al.. (2000). Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. Blood. 95(12). 3683–3686. 12 indexed citations
11.
Kulkarni, Samar, R Powles, Jennie Treleaven, et al.. (2000). Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. Blood. 95(12). 3683–3686. 101 indexed citations
12.
13.
Sumpter, Kate, R Powles, Noopur Raje, et al.. (1999). Oral Idarubicin as a Single Agent Therapy in Patients with Relapsed or Resistant Multiple Myeloma. Leukemia & lymphoma. 35(5-6). 593–597. 8 indexed citations
14.
Mehta, Jayesh, R Powles, Jennifer Treleaven, et al.. (1999). The Impact of Karyotype on Remission Rates in Adult Patients withde novoAcute Myeloid Leukemia Receiving High-Dose Cytarabine-Based Induction Chemotherapy. Leukemia & lymphoma. 34(5-6). 553–560. 10 indexed citations
15.
Sirohi, Bhawna, R Powles, Jayesh Mehta, et al.. (1999). Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed disease entity with a new staging system. British Journal of Haematology. 107(3). 656–666. 25 indexed citations
16.
17.
18.
19.
20.
Mehta, Jayesh, R Powles, Jennie Treleaven, et al.. (1997). Number of Nucleated Cells Infused During Allogeneic and Autologous Bone Marrow Transplantation: An Important Modifiable Factor Influencing Outcome. Blood. 90(9). 3808–3810. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmen Martín Breakdown of academic impact, for papers by Ming Jiang Breakdown of academic impact, for papers by Sabine Fürst Breakdown of academic impact, for papers by DW Beelen Breakdown of academic impact, for papers by A Iriondo Breakdown of academic impact, for papers by R Clift Breakdown of academic impact, for papers by W-S Min Breakdown of academic impact, for papers by Pascual Balsalobre Breakdown of academic impact, for papers by Joachim Deeg Breakdown of academic impact, for papers by James Gajewski
Rankless by CCL
2026